Brief: Oxford Biomedica Expects FY 2025 Revenues To Increase 30%
24/02/2026 07:17
Feb 24 (Reuters) - Oxford BioMedica PLC OXB.L: OXFORD BIOMEDICA PLC - EXPECTS FY 2025 REVENUES TO INCREASE 30% TO £166-169 MILLION OXFORD BIOMEDICA PLC - EXPECTS FY 2025 OPERATING EBITDA MID-TO-HIGH SINGLE-DIGIT £ MILLION OXFORD BIOMEDICA PLC - EXPECTS FY 2026 REVENUES £220-240 MILLION, 25-30% GROWTH IN 2027-2028 OXFORD BIOMEDICA PLC - EXPECTS OPERATING EBITDA MARGIN TO EXCEED 10% IN FY 2026 Source text: ID:nRSX1598Ua Further company coverage: OXB.L